Fernwood Investment Management’s Relay Therapeutics RLAY Stock Holding History

Fernwood Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$765K	Hold	185,763	–	–	0.27%	78
2024 Q3	$1.32M	Hold	185,763	–	–	0.43%	61
2024 Q2	$1.21M	Hold	185,763	–	–	0.38%	67
2024 Q1	$1.54M	Buy	185,763 +700	+0.4%	+$6.83K	0.45%	58
2023 Q4	$2.04M	Hold	185,063	–	–	0.67%	38
2023 Q3	$1.56M	Hold	185,063	–	–	0.56%	51
2023 Q2	$2.32M	Hold	185,063	–	–	0.82%	33
2023 Q1	$3.05M	Hold	185,063	–	–	1.17%	20
2022 Q4	$2.76M	Hold	185,063	–	–	1.14%	21
2022 Q3	$4.14M	Hold	185,063	–	–	1.75%	12
2022 Q2	$3.1M	Hold	185,063	–	–	1.34%	19
2022 Q1	$5.54M	Hold	185,063	–	–	1.94%	11
2021 Q4	$5.68M	Hold	185,063	–	–	1.86%	12
2021 Q3	$5.83M	Hold	185,063	–	–	2%	9
2021 Q2	$6.77M	Hold	185,063	–	–	2.24%	10
2021 Q1	$6.4M	Buy	185,063 +19,424	+12%	+$843K	2.35%	9
2020 Q4	$6.88M	Hold	165,639	–	–	2.71%	6
2020 Q3	$7.05M	Buy	+165,639	New	+$6.32M	3.33%	3

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fernwood Investment Management's RLAY Position: Q4 2024 in Review

Fernwood Investment Management held its Relay Therapeutics (RLAY) position steady in Q4 2024 at 185,763 shares worth $765K. The position accounts for 0.27% of the portfolio, ranked #78.

Fernwood Investment Management first reported a position in RLAY in Q3 2020 and has held it in 18 quarters since. The position peaked at $7.05M in Q3 2020. 199 funds tracked by Wall St. Rank hold RLAY as of Q4 2024.

Fernwood Investment Management held 185,763 shares of Relay Therapeutics worth $765K as of Q4 2024.
Fernwood Investment Management left its Relay Therapeutics share count unchanged in Q4 2024.
Relay Therapeutics made up 0.27% of Fernwood Investment Management's portfolio in Q4 2024, its #78 holding.
Fernwood Investment Management first reported a position in Relay Therapeutics in Q3 2020 and has held it in 18 quarters since.
Fernwood Investment Management's Relay Therapeutics position peaked at $7.05M in Q3 2020.
199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.